“With proper patient selection survival with chemotherapy can be just as good as with surgery or even better.”
— Dr. Gunnar Hillerdal, Karolinksa University Hospital
SEOUL, KOREA — September 28, 2007 — Patients who have been diagnosed with malignant mesothelioma are living longer, according to a Nordic collaborative group that spoke at the 12th World Conference on Lung Cancer in Seoul, Korea. The study showed that victims specifically suffering with epithelial mesothelioma who were treated with chemotherapy alone survived an average of 15 months after diagnosis, and some patients lived for more than three years.
Friday, April 10, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment